发明名称 Gesubstitueerde oxazolidinonen en toepassing daarvan op het terrein van Rivaroxaban, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, hydraat of hydraat van het zout
摘要 N-oxazolidinylmethyl-substituted (benzo)thiophene carboxamides (I) and their salts, hydrates and prodrugs are new. - N-oxazolidinylmethyl-substituted (benzo)thiophene carboxamides of formula (I) and their salts, hydrates and prodrugs are new. - R1 = optionally benzo-fused thiophene, optionally substituted one or more times; - R2 = any selected organic group; - R3-R8 = same or different hydrogen or 1-6C alkyl. - Excluded are compounds where R2 = phenyl (optionally substituted once or more) and all of R3-R8 are hydrogen. - Independent claims are also included for the following: - (1) preparation of (I); and - (2) pharmaceutical composition containing (I), optionally also auxiliaries and carriers. - ACTIVITY - Anticoagulant; cardiant; anti-anginal; vasotropic; thrombolytic; cerebroprotective; antiarthritic; antiarteriosclerotic; cytostatic; nootropic; neuroprotective. - Test details are described but no results given. - MECHANISM OF ACTION - Coagulation factor Xa Inhibitor.
申请公布号 NL300370(I2) 申请公布日期 2009.05.06
申请号 NL20080300370C 申请日期 2008.11.25
申请人 BAYER HEALTHCARE AG 发明人
分类号 A61K31/42;A61K31/422;A61K31/423;A61K31/424;A61K31/427;A61K31/428;A61K31/4365;A61K31/444;A61K31/454;A61K31/496;A61K31/5355;A61K31/5377;A61K31/538;A61K31/5383;A61K31/541;A61P7/00;A61P7/02;A61P9/10;A61P19/02;A61P25/28;A61P35/00;A61P43/00;C07D413/12;C07D413/14;C07D417/14;C07D495/04;C07D498/04 主分类号 A61K31/42
代理机构 代理人
主权项
地址